CVD

Morehouse School of Medicine, Sickle Cell Foundation of Georgia and 23andMe Launch Sickle Cell Carrier Status Awareness Program

Retrieved on: 
Tuesday, April 11, 2023
Lijun International Pharmaceutical (Holding) Co. Ltd., 23andMe, Genetics, Sickle cell trait, American Heart Association, National Science Foundation, SCFG, SCD, Health equity, MSM, Research, CVD, National Institutes of Health, Black, Bangladesh Technical Education Board, Morehouse School of Medicine, Student, National Football League Players Association, Apple Corps, Anti-transglutaminase antibodies, Hemoglobin subunit beta, SCT, Sickle cell disease, Genetic testing, Faculty, Health, FDA, HBB, African Americans, Mobile phone, Nursing, Pharmaceutical industry, UnitedHealth Group

ATLANTA and SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Today, 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, Morehouse School of Medicine (MSM), and the Sickle Cell Foundation of Georgia (SCFG) announced the launch of a Sickle Cell Carrier Status Awareness program to help increase access to sickle cell carrier status information, raise awareness of sickle cell disease (SCD), and offer resources for individuals with sickle cell trait (SCT) and SCD.

Key Points: 
  • Program aims to increase access to information on sickle cell carrier status, and offer resources to individuals with sickle cell trait and sickle cell disease
    ATLANTA and SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Today, 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, Morehouse School of Medicine (MSM), and the Sickle Cell Foundation of Georgia (SCFG) announced the launch of a Sickle Cell Carrier Status Awareness program to help increase access to sickle cell carrier status information, raise awareness of sickle cell disease (SCD), and offer resources for individuals with sickle cell trait (SCT) and SCD.
  • This includes genetic reports on several conditions that disproportionately affect the Black and African American community, including a Carrier Status report on sickle cell anemia*.
  • Program participants will also be offered counseling by the Sickle Cell Foundation of Georgia after receiving their 23andMe results.
  • 23andMe’s FDA-authorized Sickle Cell Anemia Carrier Status report tests for the HbS variant in the Hemoglobin Subunit Beta (HBB) gene, which is linked to sickle cell anemia and other forms of SCD.

mRNA Vaccines and Therapeutics Global Market Report 2023: Sector to Reach $66.2 Billion by 2028 at a 2.8% CAGR - ResearchAndMarkets.com

Retrieved on: 
Friday, April 7, 2023
Health, Pharmaceutical, Vaccine, CVD, Therapy, Prevalence, Diabetes, HIV, Biotechnology, Cancer, Research, Messenger, Tuberculosis, Viral, R, Attenuated vaccine, Growth

The "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022.
  • Looking forward, the publisher expects the market to reach US$ 66.2 Billion by 2028, exhibiting a CAGR of 2.8% during 2022-2028.
  • The publisher provides an analysis of the key trends in each sub-segment of the global mRNA vaccines and therapeutics market report, along with forecasts at the global, regional and country level from 2023-2028.

Digital Health Market to Hit $809.2 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Wednesday, April 12, 2023
Infection, Maintenance, Telehealth, IBM, Component, National Data Sharing and Accessibility Policy – Government of India, Prevalence, Diabetes, Internet, COVID-19, Cancer, Software, CVD, Tech, USD, Government, MHealth, EHealth, Digital health, Physician, SAN, EHR, Apple, Conditional sentence, Growth, Revenue, Mobile phone, Retail

SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- The global digital health market size is expected to reach USD 809.2 billion by 2030.

Key Points: 
  • SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- The global digital health market size is expected to reach USD 809.2 billion by 2030.
  • Read full market research report for latest industry insights, " Digital Health Market Size, Share & Trends Analysis Report By Technology (Healthcare Analytics, mHealth, Tele-healthcare, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • For instance, during the 2022 budget session, the Government of India introduced a digital health ecosystem under Ayushman Bharat Digital Health Mission (ABDM).
  • Grand View Research has segmented the digital health market based on technology, component, and region
    Digital Health Market - Technology Outlook (Revenue, USD Million, 2016 - 2030)

Digital Health Market to Hit $809.2 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Wednesday, April 12, 2023
Infection, Maintenance, Telehealth, IBM, Component, National Data Sharing and Accessibility Policy – Government of India, Prevalence, Diabetes, Internet, COVID-19, Cancer, Software, CVD, Tech, USD, Government, MHealth, EHealth, Digital health, Physician, SAN, EHR, Apple, Conditional sentence, Growth, Revenue, Mobile phone, Retail

SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- The global digital health market size is expected to reach USD 809.2 billion by 2030.

Key Points: 
  • SAN FRANCISCO, April 12, 2023 /PRNewswire/ -- The global digital health market size is expected to reach USD 809.2 billion by 2030.
  • Read full market research report for latest industry insights, " Digital Health Market Size, Share & Trends Analysis Report By Technology (Healthcare Analytics, mHealth, Tele-healthcare, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2023 - 2030 ", published by Grand View Research.
  • For instance, during the 2022 budget session, the Government of India introduced a digital health ecosystem under Ayushman Bharat Digital Health Mission (ABDM).
  • Grand View Research has segmented the digital health market based on technology, component, and region
    Digital Health Market - Technology Outlook (Revenue, USD Million, 2016 - 2030)

UM SCHOOL OF MEDICINE RESEARCHERS CHART PATH FORWARD ON DEVELOPING MRNA VACCINES FOR INFECTIONS BEYOND COVID-19

Retrieved on: 
Friday, April 7, 2023
BioNTech, Injection, The New England Journal of Medicine, Medical Affairs Bureau, Pfizer, Human, University, Pediatric emergency medicine, Pediatrics, HIV, Vaccination, COVID-19, University of Maryland, College Park, Clinical trial, World Health Organization, Messenger, Plasmodium, Infection, CVD, Research, Cell, United Nations Foundation, Antibody, NEJM, Maryland School, PfSPZ Vaccine, Global Health, Death, Incidence, Influenza, Pandemic, United Nations, COVID-19 vaccine, Risk, University of Maryland School of Medicine, Disease, SE, Faculty, Mortality, Safety, Myron, RTS, Malaria, Vaccine, Science, Medicine, FIDSA, MD, MPH

BALTIMORE, April 7, 2023 /PRNewswire/ -- After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of Medicine (UMSOM) researchers and scientists are turning their attention to utilizing this innovative technology to ward off other infectious diseases like malaria and influenza. Last month, UMSOM faculty in the Center for Vaccine Development and Global Health (CVD) launched a new clinical trial to investigate the use of mRNA technologies to create a vaccine against malaria. CVD Director Kathleen M. Neuzil, MD, MPH, FIDSA also provided commentary in the nation's leading medical journal on the feasibility of using mRNA to develop a universal influenza vaccine that could eliminate the need for seasonal shots.

Key Points: 
  • The huge success of mRNA vaccines to combat COVID-19 has opened up a new era in vaccine development, offering the potential for faster, more efficient, and more effective vaccine production.
  • Dr. Neuzil pointed to more than 20 studies underway or in the planning stages to test novel influenza vaccines utilizing this technology.
  • She commented on a recent animal study published in Science, which tested an mRNA vaccine against all 20 known influenza virus subtypes.
  • CVD researchers also recently launched a new clinical trial investigating an mRNA-based vaccine for malaria.

Global Medical Device Manufacturing Outsourcing Market Projected to Exceed $104.3 Million, at 10.3% CAGR from 2019 to 2026 [215-Pages] | Analysis by Research Dive

Retrieved on: 
Friday, March 31, 2023
Medical device, CVD, Diabetes, Class, Cancer, Investment, Risk, SCSI Peripheral Device Type, Consumables, IVD, Conditional sentence, Growth, WHO model list of essential in vitro diagnostics, Center for Urban and Regional Analysis, Research, Pet industry

NEW YORK, March 31, 2023 /PRNewswire/ -- Research Dive has added a new report to its offering titled, "Medical Device Manufacturing Outsourcing Market, by Device Type (Cardiovascular, IVD (Consumable, Equipment), Diabetes Care, Dental, Drug Delivery, Orthopedic, Endoscopy Devices, Ophthalmic), Service (Quality Management Services, Final Goods Assembly Services, Device Development and Manufacturing Services), Class of Device (Class I, Class II Class III), Regional Analysis (North America, Europe, Asia Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026".

Key Points: 
  • Increasing developments & investments in the quality of healthcare are fueling the global medical device manufacturing outsourcing market growth in the 2019-2026 timeframe.
  • The global medical device manufacturing outsourcing market is projected to exceed $104.3 million by 2026, rising at a CAGR of 10.3% in the 2019–2026 timeframe.
  • Among region, the North America region market is projected to perceive notable growth and surpass $31.2 million in the forecast period.
  • However, the risk of leakage of confidential data is anticipated to hinder the market growth in the estimated timeframe.

ProQR Announces Initial Pipeline Targets and Highlights Axiomer® RNA Editing Platform Technology at R&D Event

Retrieved on: 
Wednesday, March 29, 2023
Heart, CVD, ProQR, Disease, Partnership, NTCP, University, Heart failure, Q&A, Genetics, Davis, Stroke, Cardiovascular disease, Splenic infarction, Eon, Research, Biliary atresia, Biomarker, IP, RNA, Doctor of Philosophy, Atherosclerosis, EDT, LOF, Eli Lilly, Blood, Free File Alliance, Protein, N-Acetylgalactosamine, Cholestasis, ADAR, Patient, Patent, Primate, Ophthalmology, Nervous system, Annual report, Liver, NHP, R, Liver failure, PSC, RNA editing, B4GALT1, Primary sclerosing cholangitis, Dietary supplement, Vaccine, Pharmaceutical industry, Cryptocurrency, Lilly, Axiom Space

(Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced initial pipeline programs focused on diseases that originate in the liver.

Key Points: 
  • (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced initial pipeline programs focused on diseases that originate in the liver.
  • ProQR will host a virtual R&D event today, during which the Company will showcase its proprietary Axiomer RNA-editing technology platform, detail the pipeline, and provide guidance on the advancement of programs toward the clinic.
  • ProQR today announced AX-0810 for Cholestatic Diseases targeting NTCP and AX-1412 for Cardiovascular Disease targeting B4GALT1 as initial pipeline programs.
  • Beyond this, ProQR has several unpublished patent applications and continuously invests in expanding its IP estate around ADAR-mediated RNA editing.

Personalized Nutrition and Supplements Global Market to Reach $131.62 Billion by 2030: Increasing Consumer Health Awareness Coupled with Growing Demand for Retail Nutrition Products Fuels the Sector - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 29, 2023
Fitness & Nutrition, Health, Heart, Allergy, ADM, Obesity, Metagenics, Prevalence, Diabetes, German National Library of Medicine, COVID-19, Sleep, Cardiovascular disease, Cancer, Woman, CVD, USD, Notifiable disease, Alan Berg (global nutrition advocate), Death, Incidence, National library, Acquisition, Dietary supplement, Anemia, Immune system, Conditional sentence, Growth

Nutritional supplements are majorly used for boosting immunity, energy, cognitive & mental health, as well as improving heart & digestive health.

Key Points: 
  • Nutritional supplements are majorly used for boosting immunity, energy, cognitive & mental health, as well as improving heart & digestive health.
  • The sudden shift in consumer preference toward a healthy lifestyle, including adding personalized vitamins to day-to-day regimens is also driving the market.
  • According to a report by ADM, post-COVID-19 lockdown, 60% of global consumers are aiming to enhance their overall health and wellness in the next 12 months.
  • The spike in sales of global supplements was due to the increasing awareness about the importance of a strong immune system during COVID-19.

Synthetic Diamond Global Market 2023 to 2028: Significant Growth in the Electronics Industry Creates a Positive Outlook

Retrieved on: 
Thursday, March 30, 2023
Hardness, COVID-19, Thermal conductivity, HPHT, Growth, Power, Light-emitting diode, CVD, Mining, Electronics, Telecommunications, Gemstone, Abrasive, Potash, Synthetic, UV

Significant growth in the electronics industry across the globe is creating a positive outlook for the market.

Key Points: 
  • Significant growth in the electronics industry across the globe is creating a positive outlook for the market.
  • What is the expected growth rate of the global synthetic diamond market during 2023-2028?
  • What are the key regions in the global synthetic diamond market?
  • 8. Who are the key players/companies in the global synthetic diamond market?

Global Visible Light Range Scientific Camera Market Research Report 2023: China to Emerge as a Lucrative Growth Avenue - Forecasts to 2028

Retrieved on: 
Tuesday, March 28, 2023
Hamamatsu Photonics, US Census Bureau International Data Base, EMCCD, Less, Prevalence, Noise, Cardiovascular disease, Cancer, System, CVD, USD, Teledyne Technologies, SCMOS, United States Census Bureau, Oxford Instruments, Hospital, CMOS, CCD, MP, Growth, Ageing, Digital, Region, Television, Microscope, Camera

The visible light range scientific camera market is projected to reach USD 600 million by 2028 from USD 400 million in 2023; it is expected to grow at a CAGR of 7.9% from 2023 to 2028.

Key Points: 
  • The visible light range scientific camera market is projected to reach USD 600 million by 2028 from USD 400 million in 2023; it is expected to grow at a CAGR of 7.9% from 2023 to 2028.
  • The visible light range scientific camera market, by type, has been segmented into sCMOS, sCMOS (Backthinned), CCD, CCD (Backthinned), and EM-CCD cameras.
  • The visible light range scientific camera market, by camera resolution, has been segmented into less than 4 MP, 4MP to 5 MP, 5 MP to 9MP, and more than 9 MP resolution.
  • Furthermore, technological advancements in the country are also supporting the growth of the scientific camera market.